… Furthermore, such aberrant glycan structures play key roles in the acquisition of molecular
… anti-cancer targeted agents. In this review, we highlight the impact of glycosylation in cancer …

… cancer … glycosylation machinery is associated with cancer progression and metastasis. We
also provide insights into the influence of aberrant glycosylation in the development of cancer …

… receptors lead to many diseases, including cancer. These alterations give rise to micro- …
glycosylation and its regulatory function in autoimmunity and aberrant glycosylation in cancer. …

… The importance of altered glycosylation of tumor in disease progression has been well
documented (14). In the following sections, we focused on the aberrant glycosylation in CSC …

… but dramatically and markedly decreased in colon cancer. … to the aberrant sialylation-related
diseases, such as cancers will … the altered sialylation on epithelial ovarian cancers (EOCs). …

… glycosylation is considered a hallmark of cancer and other diseases. A large number of
studies have shown that aberrant glycosylation is … In fact, it has been found that glycosylation …

… Altered glycosylation as a hallmark of cancer Aberrant glycosylation in human cancer was
initially suggested by Hakomori and his colleagues as evidenced by the marked accumulation …

… Strategies for targeting the aberrant glycans are currently … aberrant glycosylation as
therapeutic targets for solid tumors. … The altered glycosylation with unique structures in cancers, …

… Cancer cells have a different ‘glycan coat’ to healthy cells and aberrant glycosylation is a
universal feature of cancer cells linked to all of the cancer hallmarks. This means glycans hold …

Background Changes in protein glycosylation are widely observed in tumor cells. N-glycan
branching through adding β1,6-linked N-acetylglucosamine (β1,6-GlcNAc) to an α1,6-linked …